InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Warner Robert Keith, Director. Director active across 2 companies, notably RxSight, Inc.. In total, 13 disclosures have been recorded. Split: 0 buy · 2 sells. Total volume traded: €1.1m. Activity tracked since 3 August 2021. The latest transaction was disclosed on 24 April 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations
Warner Robert Keith is an Administrateur and reports transactions for RxSight, Inc. and Inari Medical, Inc. Across 13 filings, the 13 sampled filings cover the period from 2021-08-05 to 2025-06-04, with sum_buy_eur at 0 and sum_sell_eur at 1110519. The main sampled filings include sales of EUR 640078.7811136732 on 2024-01-09 at RxSight, Inc. and EUR 470440.6750128144 on 2023-12-12 at RxSight, Inc., as well as Attribution-type transactions at Inari Medical, Inc. and RxSight, Inc.